NAFDAC Debunks Viral Claim That Camosunate Has Been Banned in Nigeria
NAFDAC says claims that it has banned Camosunate, an antimalarial containing artesunate and amodiaquine, are false. The agency says it has not banned the medicine or other products containing that combination. The agency noted that nausea, vomiting, diarrhoea, abdominal pain, headache, dizziness, drowsiness and loss of appetite can be known side effects. Anyone who suspects an adverse reaction should report it through the NAFDAC Med Safety App or at a NAFDAC office. NAFDAC urged Nigerians to stop sharing the unverified claim and to share its clarification instead. The statement was issued on November 21, 2026.
Stories are shared by community members. This article does not represent the official view of NaijaWorld — the author is solely responsible for its content.

